S. Pillai et al., Ceramide potentiates, but sphingomyelin inhibits, vitamin D-induced keratinocyte differentiation: comparison between keratinocytes and HL-60 cells, ARCH DERM R, 291(5), 1999, pp. 284-289
Differentiation of epidermal keratinocytes and leukemia HL-60 cells induced
by 1,25-dihydroxyvitamin D [1,25(OH)(2)D] has been reported to be mediated
, at least in part, by increases in cellular ceramide levels. Ceramides pro
duced by 1,25(OH)(2)D-induced sphingomyelin (SM) hydrolysis also contribute
to the permeability barrier lipids in keratinocytes. Exogenously supplied
SM is taken up by mammalian cells, including keratinocytes, and is incorpor
ated into cellular pools. However, the effects of exogenously added SM on k
eratinocyte differentiation have not been studied. Therefore, in this study
, we compared exogenously added SM with a cell-permeable ceramide for their
ability to stimulate keratinocyte differentiation induced by 1,25(OH)(2)D.
Both short-chain ceramide (C2-cer) and SM stimulated the differentiation a
nd inhibited the proliferation of HL-60 cells. As expected, this effect was
potentiated by 1,25(OH)(2)D. However, SM inhibited the differentiation and
stimulated the proliferation of keratinocytes. While C2-cer potentiated th
e effects of 1,25(OH)(2)D, SM reversed the effects of 1,25(OH)(2)D on kerat
inocytes. The ratio of SM to ceramide was significantly different between k
eratinocytes and HL-60 cells. While the SM Level of HL-60 cells were twice
that of keratinocytes, keratinocytes contained ten times more ceramides tha
n HL-60 cells, resulting in a ceramide/SM ratio 17 times higher in keratino
cytes. Thus, me identified similarities and significant differences in the
sphingolipid-mediated cell signaling pathway between keratinocytes and HL-6
0 cells. While SM stimulated HL-60 cell differentiation, presumably by inco
rporation into SMase-accessible membrane pools, it inhibited keratinocyte d
ifferentiation. In keratinocytes, SM was possibly incorporated into a diffe
rent cellular pool (barrier lipid pool) or altered membrane phospholipid me
tabolism and membrane fluidity.